23andMe is set to go public in a merger with a SPAC backed by Sir Richard Branson. Company co-founder and CEO Anne Wojcicki and Branson himself discuss the “delight” offered by the company’s genetic sequencing, and they look ahead to what they’re hoping is a lucrative future. In a special conversation exclusive to Squawk Pod, Joe Kernen reflects on his own family’s journey with 23andMe, including the highs and lows of finding long lost blood connections. Plus, Johnson and Johnson has asked the FDA for emergency use authorization for its vaccine, and former FDA Commissioner Dr. Scott Gottlieb says an approval could hasten the country’s herd immunity.